Skip to content

Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice

Therapept

Synthetic tetrapeptide

Epitalon

A synthetic tetrapeptide with no approved drug product. It is distinct from Epithalamin, a pineal extract, with which it is sometimes conflated in supplier documentation.

Also listed as: Epithalon, AEDG peptide, Ala-Glu-Asp-Gly

Chemical identity

Compound class
Synthetic tetrapeptide
Sequence
AEDG
Molecular formula
C14H22N4O9
Molecular weight
390.35 g/mol
CAS number
307297-39-8
PubChem CID
219042
Research categories
Peptide fragments, Preclinical research compounds

United States regulatory status

No FDA-approved product

  • No approved drug product exists in Drugs@FDA.
  • Listed on FDA's table of bulk substances nominated for compounding and withdrawn by the nominator, citing aggregation and impurity immunogenicity risk and absence of safety information.
  • Considered at FDA's Pharmacy Compounding Advisory Committee meeting of 24 July 2026. No vote outcome had been published at the time of review.
  • Not named on the WADA 2026 Prohibited List.

Regulatory status describes how a substance is classified. It is not a safety assessment, and it says nothing about the quality of any particular material.

Sources

  1. PubChem CID 219042
  2. FDA — Certain bulk drug substances for use in compounding may present significant safety risks

Last reviewed 3 September 2026 · Compiled by Therapept Editorial · How these records are built